Related Experiment Video
Updated: May 5, 2026

14:14
Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
Published on: December 11, 2017
14.8K
Septal leaflet augmentation during Da Silva cone repair: Valvar function and anatomic features compared to nonpatch
Veenah K Stoll1, Jose P Da Silva1, Krithika Sundaram2
1Division of Pediatric Cardiothoracic Surgery, Department of Cardiothoracic Surgery, UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pa.
The Journal of Thoracic and Cardiovascular Surgery
|March 12, 2026
Summary
Autologous pericardial patch augmentation during Cone repair for Ebstein's anomaly (EA) shows comparable tricuspid valve (TV) function and re-operation rates. This technique effectively complements EA repair, improving TV outcomes.
Area of Science:
- Cardiovascular Surgery
- Congenital Heart Disease
- Cardiac Repair Techniques
Background:
- Ebstein's anomaly (EA) is a rare congenital heart defect affecting the tricuspid valve (TV).
- Cone repair (CR) is a surgical technique used to address EA, aiming to restore TV function.
- Septal leaflet augmentation is a critical component of CR, and the use of autologous pericardial patches is an evolving strategy.
Purpose of the Study:
- To evaluate the outcomes of Da Silva Cone repair (CR) using autologous pericardial patch for septal leaflet augmentation in Ebstein's anomaly (EA).
- To identify specific tricuspid valve (TV) morphologies associated with the utilization of pericardial patches during CR.
- To compare TV function and re-operation rates between patients who received patch augmentation and those who did not.
Main Methods:
- A single-site retrospective study included 108 patients undergoing CR for EA between January 2016 and November 2024.
- Patients were divided into two groups: those who received an autologous pericardial patch for septal leaflet augmentation and those who did not.
- Outcomes assessed included TV function (stenosis or regurgitation) and a composite of re-operation or >moderate residual tricuspid regurgitation (TR). Adjusted regression analyses were performed.
Main Results:
- Of 108 patients, 50 received a patch. Patch patients were older (13.1 vs. 6.9 years).
- Tricuspid regurgitation (TR) improved significantly post-CR in both groups (78.7% to 79.0%).
- TV function and re-operation rates were comparable between patch and non-patch groups (6.0% vs. 1.7%), with a median follow-up of 1.1 years. Factors associated with patch use included multiple TV orifices, absence of severe inferior leaflet displacement, and absence of extreme TV rotation.
Conclusions:
- Autologous pericardial patch augmentation of the septal leaflet is an effective complementary technique during Cone repair for Ebstein's anomaly.
- This approach provides comparable early tricuspid valve function and freedom from re-operation.
- The findings support the use of pericardial patches in specific EA morphologies to optimize surgical repair outcomes.
Related Concept Videos
Mitral Valve Prolapse I: Introduction
1.1K
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
1.1K
Mitral Valve Prolapse II: Assessment and Management
1.4K
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
1.4K

